[1] |
Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al.
Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
|
[2] |
Yuan Chunhui, Li Chunyu, Li Hongli.
Efficacy of pegylated interferon α -2b in the treatment of patients with serum HBeAg positive chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 353-356.
|
[3] |
Wang Ming, Zhang Shu, Li Ming, Wen Jun, Zheng Zhenjiang.
Comparative study of serum and fecal HBV DNA in patients with chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 176-179.
|
[4] |
Yuan Chunhui, Li Chunyu, Li Hongli, Zhao Hongna, Wen Wenhong, Meng Qingxu, Zhang Zhongxue.
Impact of blood IL28B gene polymorphism on viralogic response in patients with HBeAg positive chronic hepatitis B receiving peginterferon alfa therapy
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 184-187.
|
[5] |
Baoyan, Wang Yun, Xiang Xiaogang, et al..
Prognosis of patients with hepatocellular carcinoma and underlying hepatitis B An
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 924-927.
|
[6] |
ZhangLining, Liu Zhigang, GaoCaixia, et al..
Application of dietary intervention with authorized education in patients with hepatitis B virus associated glomerulonephritis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 799-800.
|
[7] |
Wang Ping, Zhou Xiaojia, Liu Xinhua.
Application of video-based health education in patients with hepatitis B virus associated glomerulonephritis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 451-452.
|
[8] |
Weng Yerui, Fu Aizhen.
Investigation of milk HBV DNA in pregnant women with chronic HBV infection
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 457-458.
|
[9] |
Zhang Haiyue, Wang Luwen, Liu Feifei, et al.
Serum HBsAg levels in prognosis of serological response to nucleos(t)ide analog therapy in patients with HBeAg positive chronic hepatitis B:a Meta-analysis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 191-195.
|
[10] |
Zhang Chenxi, Li Shaohao.
Application of telbivudine and entecavir in treatment of patients with serum HBeAg-positive hepatitis B who failed to response to Peg-IFN α-2a therapy
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 281-282.
|
[11] |
Zhan Guoqing, Tan Huabing, Li Fang, et al.
Effect of antiviral therapy with entecavir on HBV reactivation in serum HBV DNA negative hepatitis B virus infection-reduced patients with hepatocellular carcinoma receiving transcatheter arterial chemoemholization
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 96-99.
|
[12] |
Zhang Shitong, Jin Jianjun, Bai Yanli, et al.
Efficacy of enticavir on long-term survival in patients with serum HBV DNA negative hepatitis B-induced primary liver cancer after TACE
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(1): 100-103.
|
[13] |
Zhou Yun, Li Sheng, Tang Zongsheng, et al..
Serum HBsAg and HBeAg changes in pCMV2/IFN-α4 plasmid-infected mice
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 483-485.
|
[14] |
Ma Yong..
Prevalence of hepatitis B infection in infants with hepatitis B virus-carrying mothers
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 486-487.
|
[15] |
Deng Xin, Wu Jian..
Plasma miR-181a levels in patients with chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 494-495.
|